Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD
Sponsor: University Hospital, Basel, Switzerland
Summary
This study investigates DDH-LSD, a novel LSD-like compound expected to have a shorter duration of action than LSD. In healthy volunteers, pharmacokinetics, safety, and subjective effects, will be assessed and compare with LSD in a controlled cross-over study.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2026-03-06
Completion Date
2028-07
Last Updated
2026-03-10
Healthy Volunteers
Yes
Conditions
Interventions
DDH-LSD
Single oral dose of DDH-LSD at the dose determined in Substudy 1. Participants are monitored for 13 hours for pharmacokinetics, subjective effects, autonomic responses, and safety parameters.
LSD
Single oral dose of 0.1 mg LSD. Participants are monitored for 13 hours for pharmacokinetics, subjective effects, autonomic responses, and safety parameters.
Placebo
Single oral administration of placebo. Participants are monitored for 13 hours under identical conditions to control for expectancy and procedural effects.
Locations (1)
University Hospital Basel
Basel, Switzerland